David Feltquate
Chief Medical Officer · iTeos Therapeutics, Inc.
Individual
- 2024
- Aug 29, 2025
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as David Feltquate. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ansbert Gadicke - $8.32M in ITOS purchases and sales on record
- MPM BioVentures 2014, L.P. - $5.08M in ITOS purchases and sales on record
- Matthew Gall - $39K in ITOS purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Feltquate?
David Feltquate is a corporate insider, tracked as Chief Medical Officer of iTeos Therapeutics, Inc. (ITOS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did David Feltquate last file a Form 4?
The most recent primary Form 4 on record is dated 29 August 2025, one of 2 filings going back to 2024.
